Stanley J Szefler
Szefler, Stanley J., 1948-....
Szefler, S. J.
Szefler, Stanley J.
Szefler, Stanley.
Szefler, S.J. (Stanley J.)
Szefler, S. J. (Stanley James), 1948-
VIAF ID: 84856106 (Personal)
Permalink: http://viaf.org/viaf/84856106
Preferred Forms
- 100 0 _ ‡a Stanley J Szefler
- 200 _ | ‡a Szefler ‡b Stanley J. ‡f 1948-....
-
-
- 100 1 _ ‡a Szefler, S. J.
- 100 1 _ ‡a Szefler, S. J.
-
-
-
-
- 100 1 _ ‡a Szefler, Stanley J.
-
-
- 100 1 _ ‡a Szefler, Stanley J. ‡d 1948-
- 100 1 _ ‡a Szefler, Stanley J. ‡d 1948-
- 100 1 _ ‡a Szefler, Stanley J., ‡d 1948-....
-
4xx's: Alternate Name Forms (13)
Works
Title | Sources |
---|---|
Childhood asthma | |
Corticosteroids in respiratory allergy | |
Dywersja w ekonomice. | |
Ekonomia polityczna socjalizmu dla studiów technicznych i rolniczych : praca zbiorowa | |
Medication Labeling for Children: Where is it Going? | |
Medicina personalizada en el asma | |
Meeting needs of infants and young children with asthma : new developments in nebulized corticosteroid therapy | |
Minimizing attrition in a long-term clinical trial of pediatric asthma | |
Monitoring and adherence in asthma management. | |
Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings? | |
More Than a Decade Follow-up in Severe or Difficult-to-Treat Asthma: TENOR II. | |
Most nocturnal asthma symptoms occur outside of exacerbations and associate with morbidity | |
The natural history of asthma and early intervention | |
Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial | |
The need for pediatric studies of allergy and asthma medications | |
New and future strategies to improve asthma control in children | |
No dose effect observed with chronic fluticasone propionate on growth velocity in children | |
Nowe spojrzenie na leczenie astmy oskrzelowej u dzieci | |
Okupacyjne drogi | |
Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience | |
P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy | |
Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma | |
Pediatric allergy : principles and practice | |
Pediatric asthma: an approach to pharmacogenetics analysis | |
Pediatric asthma - moving ahead faster than ever. | |
Personalizing asthma management for the clinician. | |
The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial | |
Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma | |
Predictors of poor response during asthma therapy differ with definition of outcome | |
Predictors of response to tiotropium versus salmeterol in asthmatic adults | |
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations | |
Prevalence of asthma-like symptoms in young children | |
Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects: Rome, Italy/Vatican City. 27-29 April 2017. | |
Race is associated with differences in airway inflammation in patients with asthma | |
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children | |
Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma | |
Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma | |
Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children | |
Reply: To PMID 24290281. | |
Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective | |
Role of budesonide as maintenance therapy for children with asthma | |
Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma. | |
Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experience | |
Seasonal risk factors for asthma exacerbations among inner-city children | |
Seasonal variation in asthma exacerbations in the AUSTRI and VESTRI studies | |
Severe Asthma in Pediatric Patients. Pathophysiology and Unmet Needs | |
Severe asthma : pathogenesis and clinical management | |
Single-dose pharmacokinetics of roflumilast in children and adolescents | |
Sleep duration, sleep hygiene, and insomnia in adolescents with asthma | |
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids | |
Stakeholder Perspectives on Optimizing Communication in a School-Centered Asthma Program | |
Steroid-unresponsive asthma | |
Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial | |
Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy | |
Systemic effect comparisons of six inhaled corticosteroid preparations | |
Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients. | |
Tiotropium bromide step-up therapy for adults with uncontrolled asthma | |
Tiotropium for the treatment of asthma in adolescents | |
Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype | |
Understanding mild persistent asthma in children: the next frontier | |
Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial | |
Use of Oral Corticosteroids in the Wheezy Toddler | |
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial | |
Wczoraj, dziś, jutro gospodarki Polski. | |
What is a clinically meaningful change in exhaled nitric oxide for children with asthma? | |
Where does worsening asthma end and an asthma exacerbation begin? | |
Zileuton : a pharmacokinetic profile | |
Znaczenie budezonidu w leczeniu podtrzymującym u dzieci chorych na astmę | |
প্রত্যুত্তর |